# Comparison of IV Lignocain and IV Dexmedetomidine for Attenuation of Laryngoscopic Stress Response to Direct Laryngoscopy

> **NCT07385040** · PHASE2,PHASE3 · COMPLETED · sponsor: **Shaheed Mohtarma Benazir Bhutto Institue of Trauma** · enrollment: 62 (actual)

## Conditions studied

- Tachycardia
- Hypertension
- Mean Arterial Pressure

## Interventions

- **DRUG:** Intravenous Dexmedetomidine infusion
- **DRUG:** Intravenous Lignocain

## Key facts

- **NCT ID:** NCT07385040
- **Lead sponsor:** Shaheed Mohtarma Benazir Bhutto Institue of Trauma
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-13
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2026-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07385040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07385040, "Comparison of IV Lignocain and IV Dexmedetomidine for Attenuation of Laryngoscopic Stress Response to Direct Laryngoscopy". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07385040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*